Top 5 Tech Stocks To Own Right Now

Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication.

Welcome to another edition of “3 Things In Biotech You Should Learn Today,” a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research.

And before we get started, if you haven’t already, be sure to check out this Progenics article that has drawn some interesting conversation from stakeholders!

Pfizer heads for gold with biosimilar rituximab

Company: Pfizer (PFE)

Therapy: Biosimilar rituximab

Disease: Indolent non-Hodgkin lymphoma

News: PFE announced that its randomized, double-blind clinical trial comparing PF-05280586 to Roche’s (OTCQX:RHHBY) rituximab has reached its primary endpoint, which was equivalence in terms of overall response rate in first-line treatment of low burden follicular lymphoma. This will likely be one of the last hurdles to be cleared before PFE moves forward with a marketing application.

Top 5 Tech Stocks To Own Right Now: Cabot Microelectronics Corporation(CCMP)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Cabot Microelectronics Co. (NASDAQ:CCMP) have received a consensus recommendation of “Buy” from the seven research firms that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month price target among analysts that have issued ratings on the stock in the last year is $114.80.

  • [By Joseph Griffin]

    News coverage about Cabot Microelectronics (NASDAQ:CCMP) has been trending somewhat positive recently, according to Accern Sentiment. Accern identifies positive and negative press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Cabot Microelectronics earned a daily sentiment score of 0.03 on Accern’s scale. Accern also gave news stories about the semiconductor company an impact score of 46.640513544039 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Cabot Microelectronics (CCMP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Cabot Microelectronics (NASDAQ: CCMP) and Analog Devices (NASDAQ:ADI) are both computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, earnings and dividends.

  • [By Ethan Ryder]

    Shares of Cabot Microelectronics Co. (NASDAQ:CCMP) have earned a consensus recommendation of “Buy” from the seven ratings firms that are currently covering the stock, Marketbeat reports. Two analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 year price target among brokerages that have covered the stock in the last year is $112.25.

Top 5 Tech Stocks To Own Right Now: Synchronoss Technologies Inc.(SNCR)

Advisors’ Opinion:

  • [By Timothy Green]

    Shares of Synchronoss Technologies (NASDAQ:SNCR) slumped on Thursday after the company said in a press release Wednesday that it would be unable to comply with Nasdaq listing requirements by the May 10 deadline. Synchronoss was threatened with delisting last November after the company failed to file quarterly results with the Securities and Exchange Commission. The stock was down about 18.5% at 12:30 p.m. EDT.

  • [By Lisa Levin]

    Breaking news

    International Flavors & Fragrances Inc. (NYSE: IFF) reported upbeat earnings for its first quarter and agreed to acquire Frutarom for $7.1 billion.
    Mondelez International, Inc. (NASDAQ: MDLZ) announced plans to acquire Tate's Bake Shop for $500 million.
    ynchronoss Technologies, Inc. (NASDAQ: SNCR) reported a deal to buy honeybee.
    DENTSPLY SIRONA Inc (NASDAQ: XRAY) reported Q1 adjusted earnings of $0.45 per share on sales of $956.1 million. The company updated its 2018 adjusted earnings guidance to $2.55 to 2.65 per share.

  • [By Dan Caplinger]

    The stock market had a generally solid performance on Monday, with large-cap indexes posting modest gains even as benchmarks that track the changes of smaller stocks underperformed. The big news of the day came on the trade front, where the White House intervened to reverse previous policy with respect to Chinese smartphone giant ZTE in an apparent effort to gain favor with the world’s most populous nation and second-largest economic power. Investors looked for potential winners from the thawing of relations with China, but not all stocks were able to avoid significant losses. Viacom (NASDAQ:VIAB), Synchronoss Technologies (NASDAQ:SNCR), and DHX Media (NASDAQ:DHXM) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Max Byerly]

    Synchronoss Technologies, Inc. (NASDAQ:SNCR) Director William J. Cadogan bought 96,152 shares of the business’s stock in a transaction that occurred on Thursday, September 6th. The shares were bought at an average price of $5.87 per share, with a total value of $564,412.24. The purchase was disclosed in a document filed with the SEC, which is available through this link.

Top 5 Tech Stocks To Own Right Now: Attunity Ltd.(ATTU)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Attunity Ltd (NASDAQ:ATTU) has earned an average recommendation of “Buy” from the six ratings firms that are currently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among analysts that have covered the stock in the last year is $12.33.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Attunity (ATTU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Attunity (ATTU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Attunity (ATTU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Tech Stocks To Own Right Now: FormFactor, Inc.(FORM)

Advisors’ Opinion:

  • [By Stephan Byrd]

    SG Americas Securities LLC grew its position in FormFactor, Inc. (NASDAQ:FORM) by 237.1% in the second quarter, Holdings Channel reports. The fund owned 27,817 shares of the semiconductor company’s stock after buying an additional 19,565 shares during the period. SG Americas Securities LLC’s holdings in FormFactor were worth $370,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Joseph Griffin]

    FormFactor, Inc. (NASDAQ:FORM) Director Michael W. Zellner sold 11,000 shares of the business’s stock in a transaction that occurred on Friday, September 7th. The stock was sold at an average price of $13.49, for a total value of $148,390.00. Following the completion of the sale, the director now owns 41,875 shares of the company’s stock, valued at $564,893.75. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

  • [By Brian Feroldi]

    FormFactor (NASDAQ:FORM), which manufactures testing equipment for semiconductor components, reported its second-quarter results on Wednesday, and as expected, the company posted year-over-year declines in revenue and profits. However, the declines were not as bad as management had projected. Margins also held up well during the trying period. Traders bid up the stock in response to the better-than-expected quarterly results and on the hope that the bottom is in the rearview mirror.

  • [By Max Byerly]

    Shares of FormFactor, Inc. (NASDAQ:FORM) have been assigned a consensus rating of “Buy” from the nine research firms that are presently covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold recommendation, four have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $17.90.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on FormFactor (FORM)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Tech Stocks To Own Right Now: Kingtone Wirelessinfo Solution Holding Ltd(KONE)

Advisors’ Opinion:

  • [By Money Morning News Team]

    While a 209% gain is exciting, FunctionX’s gains are in the past. After looking at the 10 top penny stocks to watch this week, we’ll show you a small-cap stock with serious profit potential ahead of it…

    Penny Stock Current Share Price Law Week’s Gain
    FunctionX Inc. (OTCMKTS: FNCX) $0.03 209%
    Turtle Beach Corp. (Nasdaq: HEAR) $4.48 52.73%
    DPW Holdings Inc. (NYSE: DPW) $1.16 51.31%
    Energy XXI Gulf Coast Inc. (Nasdaq: EGC) $5.62 49.33%
    MYnd Analytics Inc. (Nasdaq: MYND) $1.91 49.21%
    Kingtone Wirelessinfo Solutions Holding Ltd. (Nasdaq: KONE) $6.43 48.42%
    Rennova Health Inc. (OTCMKTS: RNVA) $0.02 44.30%
    International Tower Hill Mines Ltd. (NYSE: THM) $0.72 41.64%
    Blonder Tongue Labs Inc. (NYSE: BDR) $1.13 41.14%
    Bellicum Pharmaceuticals Inc. (Nasdaq: BLCM) $8.87 40.53%

    As the gains above suggest, penny stocks can provides tremendous returns for investors very quickly. However, it’s important to note that investing in penny stocks is also inherently risky.

Leave a Reply

Your email address will not be published. Required fields are marked *